More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

See how your savings and investment account balances can grow with the magic of compound interest. Many, or all, of the products featured on this page are from our advertising partners who ...

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...

Compared with placebo, once-weekly semaglutide significantly reduced body weight, knee osteoarthritis-related pain, and improved physical function. Topline results were announced from a phase 3 ...

Both drugs are based on the compound semaglutide. Hims & Hers (HIMS) has been marketing a compounded version of semaglutide during the shortage. According to the FDA’s website on Wednesday ...

The change comes after a prolonged shortage of these drugs, which drove demand for compounded versions. Semaglutide, the active ingredient in both drugs, has been on the FDA's shortage list for ...

Generic compounded semaglutide prescription Woman’s World has affiliate partnerships. We receive compensation when you click on a link and make a purchase. Learn more! Betterucare is one of many ...

STEP 9 was a randomized, double-blind, placebo-controlled multicenter trial designed to evaluate the efficacy of semaglutide 2.4 mg versus placebo as an adjunct to lifestyle modifications ...